Board Member
Pacira BioSciences, Inc. (PCRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
David Stack is recorded as Board Member at Pacira BioSciences, Inc. (PCRX). Pacira BioSciences, Inc. reported in an 8-K filed December 21, 2023 that David Stack retired as Chairman of the Board, effective January 1, 2024. Pacira BioSciences, Inc. reported in an 8-K filed December 21, 2023 that David Stack retired as Chief Executive Officer, effective January 1, 2024. Pacira BioSciences, Inc. reported in an 8-K filed December 21, 2023 that David Stack retired as member of the Board. Equibles holds 7 filed executive changes naming David Stack; each is listed under recent activity with its source filing. The proxy statement of Pacira BioSciences, Inc. reports total compensation of $727,378 for David Stack in fiscal 2024, including a base salary of $634,038. Disclosed compensation is on record for 6 fiscal years. David Stack has spoken on 5 earnings calls across 1 company, most recently for Pacira BioSciences, Inc. on August 2, 2023.
“David Stack will retire from his roles as Chief Executive Officer and Chairman of the Board, effective January 1, 2024, and will remain with the company through August 2025 in an advisory capacity to help ensure a smooth transition.”
“David Stack will retire from his roles as Chief Executive Officer and Chairman of the Board, effective January 1, 2024, and will remain with the company through August 2025 in an advisory capacity to help ensure a smooth transition.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2023-06-13–present
2023-06-13–2023-12-21
Start not stated–2023-12-21
Start not stated–2023-09-26
Recorded roles and call appearances connecting this person to public companies.
Board Member
2023-06-13–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Pacira BioSciences, Inc. (PCRX) | Former Chief Executive Officer | $634,038 | $727,378 |
| 2023 | Pacira BioSciences, Inc. (PCRX) | Former Chief Executive Officer | $941,387 | $6,878,091 |
| 2022 | Pacira BioSciences, Inc. (PCRX) | Former Chief Executive Officer | $910,108 | $6,851,340 |
| 2019 | Pacira BioSciences, Inc. (PCRX) | Chief Executive Officer | $831,966 | $5,806,428 |
| 2018 | Pacira BioSciences, Inc. (PCRX) | Chief Executive Officer | $807,695 | $5,835,918 |
| 2017 | Pacira BioSciences, Inc. (PCRX) | Chief Executive Officer | $784,187 | $4,718,917 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
